Cite
HARVARD Citation
Spurgeon, S. et al. (2019). Phase 1–2 study of vorinostat (SAHA), cladribine and rituximab (SCR) in relapsed B‐cell non‐Hodgkin lymphoma and previously untreated mantle cell lymphoma. British journal of haematology. pp. 845-854. [Online].